chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started giving the next injection and noticed red blotches on childs leg and chest and upper arm. I immediately got PA and then gave child 1 teaspoon of BENADRYL, oral.
Nausea on public transportation while returning home on 3/15. Fever of 99.4-99.8 on 3/16 only. Headache, body ache, elevated period cramps 3/15-3/17. Sense of smell was improved.   Continued symptom is headache and light sensitivity and difficulty remaining at work on a computer all day.   Pfizer-BioNTech COVID-19 Vaccine EUA.
Red, warm, hard 4 cm x 6 cm around injection site, the day after vaccination. On 3/18/10 had fever (not recorded by pt.). On 3/19/10 no fever but red, painful.
Severe pain in third metacarpal-phalangeal joint of right hand. Progressed to trigger finger with intense discomfort/pain.
101 degree F fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information tea. The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), on 19Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, All of my vaccinations have been Pfizer), for COVID-19 Immunization, reaction(s): "Elevated temperature"; Bnt162b2 (DOSE 2, All of my vaccinations have been Pfizer), for COVID-19 Immunization, reaction(s): "Elevated temperature"; Bnt162b2 (DOSE 3, All of my vaccinations have been Pfizer), for COVID-19 Immunization, reaction(s): "Elevated temperature". The following information was reported: PYREXIA (non-serious) with onset Apr2022, outcome "unknown", described as "101 degree F fever". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia.  Additional information: Patient got his second booster dose of the Pfizer-BioNTech COVID-19 vaccine yesterday evening [19Apr2022]. This is my is second booster. All of my vaccinations have been Pfizer. I forget what my experience was in the past, but I remember getting an elevated temperature as a side effect from it [vaccination] and now, but I'm experiencing a 101 degree F fever. The patient has an elevated temperature. The patient is wondering if the elevated temperature is normal. Patient ask "How should I manage my fever of 101 degree F after my second booster dose of the Pfizer-BioNTech COVID-19 vaccine". Running a fever of 101: The patient forgets how much fever to expect but knows fever is a side effect. The patient is running a fever of 101. The patient took Tylenol. Is fever of 101 after receiving second booster dose Pfizer Covid 19 Vaccine normal. Patient clarifies he would like to know what database puts the Pfizer Covid 19 Vaccine information in, the fact the caller received the Pfizer Covid 19 Vaccine, the lot number, etcetera, so health care provider can look up the information. Investigations, Expiry Date of Pfizer Covid 19 Vaccine and other products was not provided.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This case was reported by a physician via sales rep and described the occurrence of ankle swelling in a 16-year-old female patient who received BEXSERO for prophylaxis. Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2018-2019 season) for prophylaxis and MENACTRA for prophylaxis. Previously administered products included Flu shot (dose received each year) and MENINGOCOCCAL ACW135Y VACCINE (received 5 years ago with no issues). On 29th December 2018, the patient received BEXSERO .5 ml, Influenza vaccine Quadrivalent 2018-2019 season .5 ml and MENACTRA. On 29th December 2018, less than a day after receiving BEXSERO and Influenza vaccine Quadrivalent 2018-2019 season, the patient experienced ankle swelling, swelling of feet, foot pain, pain ankle and rash. On an unknown date, the outcome of the ankle swelling, swelling of feet, foot pain, pain ankle and rash were recovered/resolved. It was unknown if the reporter considered the ankle swelling, swelling of feet, foot pain, pain ankle and rash to be related to BEXSERO and Influenza vaccine Quadrivalent 2018-2019 season. Additional details were provided as follows: The patient received a flu shot possibly GSK flu FLUARIX or FLULAVAL 0.5ml pre-filled syringe. Within 24 hours of vaccination with BEXSERO, Influenza vaccine Quadrivalent 2018-2019 season and MENACTRA, the patient had bilateral pain in both feet and ankles with swelling, and a rash on both feet and ankles. The symptoms resolved and the physician was not sure if these were due to any of the vaccines administered. It was unknown if the reporter considered the ankle swelling, swelling of feet, foot pain, pain ankle and rash to be related to MENACTRA. The reporter agreed to be followed up.
itchy, red blistery rash on lower back side; Started 2 days after vaccine; Diagnosed with shingles on 4/27; Given antiviral medication to help with treatment
Left arm had severe soreness and pain at injection site beginning 30 minutes after administration. After approximately two hours of administration, I observed increasing numbness of extremities that did not subside for three days. Acute hypotension observed; blood pressure measured at home never exceeded 100/60
I was woken up about 12:30 - 01:00AM in morning, I had severe stomach pain resulting in vomiting and dieahhrea , it was worse then labor. I had a severe migraine, worst headache I have ever had, I got body aches and fever and chills. I wasn't able to keep anything down for a week I literally lost 20lbs in a week.  I was so weak, I couldn't speak or walk . My breathing has changed I live on inhaler now. I have lost almost 100lbs since January . My lupus is way worse now and I have severe joint pain and muscle pain and debilitating fatigue. I have lost my voice, it has not come back.
Aprox 3 min after injection, broke out in rash and hives, severe itching in neck, face, chest, tingling lips and shaking. EMS was on scene at clinic immediately removed me from car and checked vitals, BP was high 176/94, took by ambulance to ER at Medical Center. Treated in ER for 4.5 hours. Developed migraine, received benadryl, steriods,and medicine for the migraine. Sent home told take benadryl for 2 days and  do
feeling yucky; no sense of taste; headache; muscle pain; tired; This is a spontaneous report from a contactable consumer reported for boyfriend. A 58-year-old male patient received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 02Apr2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were unknown. The reporter stated the patient "started feeling yucky" on 05Apr2021. The patient had no sense of taste, a headache, muscle pain, and was tired in Apr2021. The reporter stated that she received the first dose on 02Apr2021 as well. The reporter asked if the loss of taste was a side effect of the Covid vaccine. Outcome of the events was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Information has been received from a lawyer concerning a minor male patient who on 30-DEC-2003 was vaccinated with a dose of MMR II. The lawyer reported that subsequently, some time later, in approximately 2005 and 2006 the patient began to develop autistic type symptoms and other types of medical disabilities. Subsequently it was determined by his physician that in fact this vaccine had been contaminated with mercury toxins, thereby toxifying the patient and damaging his system. The lawyer stated that at the time of the report the patient was undergoing chelation type therapy. Additional information has been requested.
No adverse effects reported.; patient received improperly stored VARIVAX; This spontaneous report was received from a nurse referring to an male child.. Information about pertinent medical history, concurrent conditions, concomitant medication and drug reactions/allergies was not provided.  On 17-APR-2019, the patient received improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) lot number R026548, and expiration date  17-SEP-2020 strength, dose detail and route were not provided) for prophylaxis (product storage error). The varicella virus vaccine live (Oka/Merck) (VARIVAX)was reconstituted with properly stored sterile diluent (lot & expiration date was unknown by reporter).   The vaccines were exposed to temperature excursion of 6 fahrenheit degree to 14 fahrenheit degree (also reported as 7.64 fahrenheit degree) for 45 minutes. The vaccines were exposed to previous temperature excursion of 6 degree Celsius to 14 fahrenheit degree (also reported as 11.28 fahrenheit degree) for 1 hour. No adverse effects reported. Data logger was involved.  This is one of several reports received from the same reporter. ; Sender's Comments:  US-009507513-1904USA008214: US-009507513-1904USA010535: US-009507513-1904USA010531: US-009507513-1904USA010532: US-009507513-1904USA010533:
12/15 Diarrhea all day & low temp 99.8 12/16 Fever all day 102.5 giving motrin Tylenol - see dr  dr said this is side effect.  12/17 Fever 101 with rash
Chills; Fever; Shaking; Headache; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the arm left on 26Apr2021 at 10:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included allergy to sulfa. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The concomitant medication was not reported. The patient previously took cefaclor (CECLOR) on an unknown date and experienced allergy. On 26Apr2021 at 23:00, the patient experienced chills, fever, shaking, headache and nausea. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, fever, shaking, headache and nausea were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Pfizer-BioNTech COVID-19 Vaccine EUA Had vaccine shot on Thursday 3/4/21 around 8:50am. The shot spot was sore for the next couple days and no other symptoms. Then on Sunday 3/7/21 night, I started having pain on the left side of my body (same side where the shot was administered). The pain was mainly from neck to should blade area first for the next couple of days, then it traveled down from my shoulder to my hand. As of the night of Thursday 3/11/21, the pain (comes on when I move my body) gets worse and I was not able to get up from bed without other's assistance. Then throughout this morning Friday 3/12/21, it seems a bit better during the day, with still pain from neck, shoulder, shoulder blade, down to the left arm and hand.
Red indurated area at and below injection site with upper arm tenderness; On 08/26/10 developed temp of 103.9F, complained of: shortness of breath, chest tightness, sensation burning feet, low back pain and fatigue.
rotator cuff problem; arm was extremely painful / what was causing this pain/injection spot pain; has been uncomfortable ever since / arm has been bothering me a lot; This case was reported by a consumer and described the occurrence of rotator cuff injury in a 65-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   In September 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 5 months after receiving Shingrix, the patient experienced rotator cuff injury, pain in extremity and discomfort. On an unknown date, the outcome of the rotator cuff injury, pain in extremity and discomfort were not recovered/not resolved.   It was unknown if the reporter considered the rotator cuff injury, pain in extremity and discomfort to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix on an unknown arm. After receiving Shingrix, the patient's arm was extremely painful for 3 days, and had been uncomfortable ever since.  The patients' arm that had the 1st injection had been bothering him/her a lot for the last 3 months from the time of reporting. The patient was uncertain as to what was causing this pain. A couple days ago from the date of reporting, the patient made a movement and thought that it was the same pain the patient experienced after receiving the initial injection. The patient's pain was so bothering that he/she went to the doctor the past week from the date of reporting. She thought, the patient might have a rotator cuff problem and was arranging physical therapy. The patient received 2nd dose in January 2020 in different arm. This case was linked with case US2020AMR096017, reported by the same reporter for the same patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR096017:same reporter
ACUTE RESPIRATORY FAILURE. 8/19/2021 ACUTE RESPIRATORY FAILURE ACUTE RESPIRATORY FAILURE 8/19/2021 HYPOKALEMIA  ACUTE RESPIRATORY FAILURE 8/19/2021 PRESENCE OF NEPHROSTOMY  ACUTE RESPIRATORY FAILURE 8/19/2021 METABOLIC ENCEPHALOPATHY
Large 5x6" red indurated area extensor surface left upper arm (does not involve shoulder or elbow). Positive pruritic and warm.
Two days post vax, pt developed redness with some pus at the injection site.  Pt was treated with acetaminophen and recovered.
Vaccine both received 1-19-17. Received FLUVIRIN and PNEUMVOAX 23. Left upper arm red, swollen, hot, went down arm. Went to ER 1-22-17. Received BACTRIM, BENADRYL, prednisone Rx.
On and off fatigue, sore throat and restricted breathing  beginning 5 hours after inoculation and continuing through to present (3+ weeks).
This spontaneous case was reported by an other health care professional and describes the occurrence of FATIGUE (Fatigue) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046L21A and 034F21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: Johnson and Johnson (primary dose). Past adverse reactions to the above products included No adverse event with Johnson and Johnson. Family history included Asthma (wife regularly uses a nebulizing inhaler) since an unknown date. Concurrent medical conditions included Cancer (NOS). On 10-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Apr-2022, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FATIGUE (Fatigue). At the time of the report, FATIGUE (Fatigue) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication were reported. Patient has been married for almost 40 years. He and his wife received all doses on the same dates from the same lot numbers. They did not experience any symptoms until 14-APR-2022. Patient did not experience nausea. No treatment drug were reported. This case was linked to MOD-2022-547521 (Patient Link).
Patient began having bells palsy like symptoms on 9/7/2021, was diagnosed on 9/9 by Dr. Patient states was given antivirals/corticosteroids. Symptoms resolved after 2 weeks.   Unsure if Dr. office has already completed a vaers report.
Approx. 2-3 minutes after the Rotateq vaccine was administered orally the infant vomited up 1-2 oz of fluid. The fluid was partially clear and some milk. The infant began choking and had to be bulb suctioned.
Patient received vaccine and was <16 years of age (15 years, 10 months)
Chills, 12 hours of severe fatigue, 4 hours of explosive diarrhea, mild nausea
Patient received his vaccine and proceeded to his car.  Once in his car, he started to experience tightness in his chest.  He drove home and once he got home he wasn't feeling any better and decided to call 911.  At the hospital, physcian determined the chest tightness was due to high dose flu vaccine.
Red, swollen, erythematous, hot to the touch.  Seen in office on 8/25/11 at 3pm treating with ABX: KEFLEX 500mg every 6 hrs x 5 days.
she did not felt great/ felt the worst that she had been feeling; temperature was like 100.3/fever; chills; This is a spontaneous report from a contactable other healthcare professional (patient herself). A 33-year-old female patient received bnt162b2 (BNT162B2 also reported as Covid19 Vaccine a Pfizer, lot EH9899, expiry date not reported), via an unspecified route of administration on 29Dec2020, single dose, for Covid-19 immunisation (prevention of Covid-19). Medical history was none. Concomitant medication included PRENATAL VITAMINS. The patient informed she did not felt great the day (29Dec2020) or 2 that when she got the vaccine. She felt the worst that she had been feeling. Her temperature was like 100.3/fever and had chills (29Dec2020). No treatment was taken. The outcome of the events was unknown.
Initial and follow up information was received from a pharmacist concerning a patient (age and gender not reported) who on 13-SEP-2013, was vaccinated with a dose of ZOSTAVAX (Lot No. J004266, exp. 12-JUL-2014) (dose and route not reported) which was exposed to 26F for 480 hours (also reported as 20 days). No adverse events were reported. This is one of several reports from the same source. Additional information is not expected.
nauseous for a couple days; felt tired; strep throat; feeling out of sync, like not right; little more tired than usual; sore throat; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 62 year-old female patient received bnt162b2 (BNT162B2, Solution for injection), administered in arm right, administration date 06May2021 14:30 (Lot number: EW0171, Expiration Date: Aug2021) at the age of 62 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "high blood pressure" (ongoing), notes: Verbatim: high blood pressure. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (product name: Covid 19 vaccine, Batch/lot number: EW0153, Anatomical site: left arm, Time of administration: 02:30 pm,, Expire date: Jul2021,, Dose no: 1), administration date: 15Apr2021, when the patient was 62 years old, for COVID-19 immunization, reaction(s): "First dose: nauseous for a couple days", "First dose: excruciating pain from the top of her chest down to her right breast", "First dose: excruciating pain from the top of her chest down to her right breast", "First dose: pressure in her head", "First dose: pressure in both her ears", "First dose: face got hot", "First dose: kidney function 62%", "First dose: D-Dimer was also elevated, it was 0.7%". The following information was reported: NAUSEA (non-serious), outcome "unknown", described as "nauseous for a couple days"; FATIGUE (non-serious), outcome "unknown", described as "felt tired"; PHARYNGITIS STREPTOCOCCAL (non-serious), outcome "unknown", described as "strep throat"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "feeling out of sync, like not right"; CONDITION AGGRAVATED (non-serious), outcome "unknown", described as "little more tired than usual"; OROPHARYNGEAL PAIN (non-serious), outcome "unknown", described as "sore throat". The events "nauseous for a couple days", "felt tired", "strep throat", "feeling out of sync, like not right", "little more tired than usual" and "sore throat" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Follow-up attempts completed. No further information expected.
Information has been received from a physician concerning an 86-year-old female with hypertension, cardiac dysrhythmias and osteoporosis who on 06-FEB-2008 was vaccinated subcutaneous with her first dose of zoster vaccine live (Oka/Merck). Concomitant therapy included losartan potassium-HCTZ (MSD) alendronate sodium (MSD) and propranolol HCL. On an unspecified date the patient experienced fullness in the head. The patient sought unspecified medical attention. The patient had a CT scan and blood work performed on an unspecified date. At the time of the report the patient's status was not recovered. A product quality complaint was not involved. Additional information has been requested.
headache; fever; body aches; joints aching; chills; sweats; nausea; diarrhea; general stomach discomfort; This case was reported by a consumer and described the occurrence of headache in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 27th July 2021, the patient received Shingrix. In July 2021, 12 hrs after receiving Shingrix, the patient experienced headache, fever, general body pain, joint pain, chills, sweating, nausea, diarrhea and stomach discomfort. On an unknown date, the outcome of the headache, fever, general body pain, joint pain, chills, sweating, nausea, diarrhea and stomach discomfort were recovered/resolved.   It was unknown if the reporter considered the headache, fever, general body pain, joint pain, chills, sweating, nausea, diarrhea and stomach discomfort to be related to Shingrix.  Additional details were provided as follows: The case was reported by the patient for herself or himself. The age at vaccination was not reported. The patient wanted to report his or her reaction to the Shingrix vaccine. The patient received the Shingrix vaccine and approximately 12 hours later the patient began to experience headache, fever, body aches, especially joints aching, chills, sweats, nausea, diarrhea, general stomach discomfort.  These was more severe symptoms lasted for about 8 hours, followed by milder stomach discomfort over two days. No further information was reported.
Swelling and pain of knees, ankles, and wrists with onset 36-48 hrs after immunization.  Treated with indomethacin.
lightheaded; hives head to toe; This is a spontaneous report from a contactable Nurse and consumer (patient). A 66-years-old non-pregnant female received BNT162B2 (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection, Lot Number and expiry date were not provided) via an unspecified route of administration on 12Jan2021 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Patient's medical history and concomitant medication were not reported. On Jan2021, patient states after injection she was lightheaded and started 2 hours later with hives head to toe. Patient was due for 2nd injection 09Feb2021. The outcome of events was unknown.  Follow-up (13May2021): Follow-up attempts completed. No further information expected.
Report 2001016915-1 describes a mass at the injection site of a 4 month old female who received an injection of Infanrix. There was no relevant medical history, concurrent illness, or concurrent medication. On 06/05/2001, the infant received her second injection of Infanrix. Unspecified concomitant vaccines were administered at "opposite sites." Later that day, she developed a 1cm area of erythema and induration and a mass at the Infanrix injection site. The infant was seen by the physician, who prescribed Tylenol 80mg every four hours for pain relief. The erythema, induration and mass resolved. The reporter considered the events to be mild in intensity and related to Infanrix administration. this is one of three infants from this facility who developed an injection site reaction following receipt of Infanrix lot DTPA992A2.
Vaccination was given 4.75 inches below the acromion process instead of the standard 2 inches